Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2003
News by month November 2003
PTCommunity News November 2003
FDA Updates Information for Physicians on Cordis Cypher Stent
Study Questions Benefits of Costly Schizophrenia Drug
IND Submitted to FDA for Xantryl, Potential Light Therapy for Psoriasis
IND Filed for AME-527, Monoclonal Antibody That Is a Potential Treatment for Rheumatoid Arthritis
FDA Approves Abarelix, Treatment for Advanced Prostate Cancer
Patient Enrollment Completed for Phase II Study of Micellar Paclitaxel in Rheumatoid Arthritis
Positive Results From Final Phase III Exenatide Study Announced
FDA Grants Fast Track Designation to C31G Vaginal Gel, Reduces HIV Transmission
FDA Approves Generic Fentanyl Transdermal System
FDA Approves Low-Dose Levonorgestrel, Estradiol Combination Transdermal Patch
Voriconazole Receives FDA Approval for Treatment of Esophageal Candidiasis
FDA Says Oncophage Clinical Trials Can Resume
FDA Panel Recommends Approval of Taxus Express<sup>2</sup> Paclitaxel-Eluting Coronary Stent System
FDA Approves Third Drug To Treat Erectile Dysfunction
Study: Ximelagatran Could Be Safe, Effective Alternative to Warfarin in Reducing Stroke
Oritavancin NDA Submission Delayed Until End of 2004
Clinical Study of Oral Form Of Methylnaltrexone Initiated
European Union Expands Fondaparinux Indication To Include Extended Use in Prophylactic Treatment
Study: Psoriasis Patients Treated With Etanercept See Skin Clearing in Two Weeks
Clinical Trials of Phenoptin, Oral Enzyme Cofactor for the Treatment of PKU, Set To Begin
Abbreviated NDA Filed for Rabeprazole Sodium Delayed-Release Tablets
Rofecoxib Shows No Effect on Markers of Cardiovascular Disease
Lansoprazole, Naproxen Combination Approved by FDA
Approvable Letter Issued for Topiramate in Migraine Prophylaxis
Two Phase III Studies of Ovine Hyaluronidase Show Significant Reduction in Vitreous Hemorrhage Density
Icatibant, Treatment for Angioedema, Gains Orphan Drug Status
FDA Approves New Treatment for COPD Associated With Chronic Bronchitis
FDA Grants Orphan Drug Designation for AEOL 10150, ALS Drug Candidate
Phase II Trial for Post-Prostatectomy Erectile Dysfunction Therapy Set To Begin
FDA Warns U.S. Residents of Diskus Asthma Medicines Sold in Canada
Phase III Results of Cinacalcet HCl Trial Demonstrate Improvement in the Management of Secondary Hyperparathyroidism
FDA Approves Piperacillin Injection
FDA Approves Metronidazole Capsules
FDA Approves Ovcon 35 as the First Chewable Oral Contraceptive Tablet for Women
Most New Users of COX-IIs May Not Need Drugs' Gastrointestinal Protection
Trials Initiated To Assess Effectiveness of Anecortave Acetate in Macular Degeneration
Phase II Trial Results of CTLA4Ig Show Efficacy in Moderate to Severe Rheumatoid Arthritis
Rituximab Reaches Efficacy Endpoint Early, Phase III Trial in Non-Hodgkin's Lymphoma Halted
FDA Grants Tentative Approval for Benazepril HCl Tablets
FDA Review of Eszopiclone NDA Extended Three More Months
FDA Approves Mupirocin Ointment
VALIANT Study Demonstrates Valsartan's Cardioprotective Benefits
Study: Glycoprotein Inhibitors Underutilized To Prevent Clots
Positive Results Announced for Long-Acting Injectable Insulin
Atorvastatin Study Shows It Halts Progression of Plaque Build-Up Better Than Pravastatin
Phase IIb Trials of Pralnacasan in Rheumatoid Arthritis Halted
Phase II Trial Evaluates Safety, Pharmacology of Adentri in Patients With Stable Heart Failure
Results of Phase III PRIMO-CABG Trial Presented at Heart Meeting
New Drug Application Filed for AV201 for the Treatment of Advanced Parkinson’s Disease
Additional Positive Results Reported for Exenatide in Second Phase III Study
CREST Study Findings Suggest Cilostazol Reduces Stent Restenosis by 40 Percent
Pixantrone Data Suggest 80 Percent Response Rate in Non-Hodgkin's Lymphoma Patients
Study Results of Sitaxsentan Use in Pulmonary Arterial Hypertension Presented at Heart Meeting
Overall Response Rate in Lymphoma Patients Unaffected By Addition of Rituximab
Phase III Clinical Trial of Toremifene Initiated
FDA Grants Final Approval for Generic Glucotrol XL Tablets
Phase III Trial Initiated of Dalbavancin for Treatment of Skin, Soft Tissue Infections
Phase II Dose Escalation Study Launched for Erlotinib
Walgreens Provides Members 90-Day Supply of Maintenance Medication
Canadian Notice of Compliance Issued for Eligard, Prostate Cancer Treatment Now Available
Positive Phase II Results Announced for Aquavan Injection Trial
Shipments for Pneumococcal Conjugate Vaccine Delayed
Combination Trial of Xcytrin With Rituxan and Zevalin for B-Cell Lymphoma Initiated
Results From Ongoing Phase I and Phase II Studies of Aryplase for MPS VI Presented
Phase III Clinical Trials for Viramidine To Be Initiated
Study Shows Infusions of Synthetic HDL Can Remove Plaque From Coronary Arteries
Study: Esomeprazole Is More Effective Than Pantoprazole in Healing Reflux Esophagitis
Treatment With Olanzapine Results in Less Hospitalization When Compared to Risperidone
Phase III Trial for Tesmilifene Set To Begin
Teriparatide Now Available in the European Union
FDA Issues Approvable Letter for Intal HFA
Phase III Trial Initiated for Tifacogin in Patients With Severe Community-Acquired Pneumonia
Emtricitabine Approved by European Commission
